Comments
FDA advisers back wider use of Abbott's Humira
29.08.2012. | WASHINGTON (Reuters) - Abbott Laboratories Inc won a U.S. panel's support on Tuesday for wider use of its blockbuster rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease....
